Cargando…
High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma
There is significant heterogeneity among multiple myeloma (MM) patients with the survival duration varying greatly from a few months to several years. This study retrospectively analyzed serum lactate dehydrogenase (LDH) in 105 cases of newly diagnosed elderly MM patients to investigate its value fo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564653/ https://www.ncbi.nlm.nih.gov/pubmed/28418851 http://dx.doi.org/10.18632/oncotarget.16237 |
_version_ | 1783258278664339456 |
---|---|
author | Gu, Yan Yuan, Ya-Hui Xu, Ji Shi, Qing-Lin Qu, Xiao-Yan Guo, Rui Bai, Hua Xu, Jia-Dai Li, Jian-Yong Chen, Li-Juan |
author_facet | Gu, Yan Yuan, Ya-Hui Xu, Ji Shi, Qing-Lin Qu, Xiao-Yan Guo, Rui Bai, Hua Xu, Jia-Dai Li, Jian-Yong Chen, Li-Juan |
author_sort | Gu, Yan |
collection | PubMed |
description | There is significant heterogeneity among multiple myeloma (MM) patients with the survival duration varying greatly from a few months to several years. This study retrospectively analyzed serum lactate dehydrogenase (LDH) in 105 cases of newly diagnosed elderly MM patients to investigate its value for outcome prediction. Serum LDH concentrations were evaluated prior to induction therapy. Prognostic analyses were carried out based on LDH levels and patients’ other clinical data. We also applied the recently proposed Revised International Staging System (R-ISS) to 70 patients with the available data. Of all the patients, elevated serum LDH levels (≥271U/L) were observed in 13.3% (14 out of 105) patients at diagnosis. Compared with normal LDH group, high LDH group had significantly shorter overall survival (OS) (15.5 vs. 52.5 months, p = 0.002) and median progression free survival (PFS) (12.0 vs. 24 months, p = 0.030), as well as 2-year OS rate (20% vs. 81%, p < 0.001) and PFS rate (22% vs. 44%, p = 0.005). A multivariate analysis identified high LDH as a unique independent adverse prognostic parameter for both OS and PFS. In addition, there were significant differences between R-ISS II and R-ISS III patients in both median OS (52.5 vs. 15.5 months, p < 0.001) and PFS (23 vs. 7.5 months, p = 0.004). Furthermore, high LDH was a unique independent adverse indicator for overall response rate (ORR) and early death in elderly MM patients. These results identified LDH as an unfavorable prediction for the outcome of Chinese elderly patients with MM. R-ISS based on LDH is superior to ISS in prognostic assessment. |
format | Online Article Text |
id | pubmed-5564653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-55646532017-08-23 High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma Gu, Yan Yuan, Ya-Hui Xu, Ji Shi, Qing-Lin Qu, Xiao-Yan Guo, Rui Bai, Hua Xu, Jia-Dai Li, Jian-Yong Chen, Li-Juan Oncotarget Clinical Research Paper There is significant heterogeneity among multiple myeloma (MM) patients with the survival duration varying greatly from a few months to several years. This study retrospectively analyzed serum lactate dehydrogenase (LDH) in 105 cases of newly diagnosed elderly MM patients to investigate its value for outcome prediction. Serum LDH concentrations were evaluated prior to induction therapy. Prognostic analyses were carried out based on LDH levels and patients’ other clinical data. We also applied the recently proposed Revised International Staging System (R-ISS) to 70 patients with the available data. Of all the patients, elevated serum LDH levels (≥271U/L) were observed in 13.3% (14 out of 105) patients at diagnosis. Compared with normal LDH group, high LDH group had significantly shorter overall survival (OS) (15.5 vs. 52.5 months, p = 0.002) and median progression free survival (PFS) (12.0 vs. 24 months, p = 0.030), as well as 2-year OS rate (20% vs. 81%, p < 0.001) and PFS rate (22% vs. 44%, p = 0.005). A multivariate analysis identified high LDH as a unique independent adverse prognostic parameter for both OS and PFS. In addition, there were significant differences between R-ISS II and R-ISS III patients in both median OS (52.5 vs. 15.5 months, p < 0.001) and PFS (23 vs. 7.5 months, p = 0.004). Furthermore, high LDH was a unique independent adverse indicator for overall response rate (ORR) and early death in elderly MM patients. These results identified LDH as an unfavorable prediction for the outcome of Chinese elderly patients with MM. R-ISS based on LDH is superior to ISS in prognostic assessment. Impact Journals LLC 2017-03-15 /pmc/articles/PMC5564653/ /pubmed/28418851 http://dx.doi.org/10.18632/oncotarget.16237 Text en Copyright: © 2017 Gu et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Clinical Research Paper Gu, Yan Yuan, Ya-Hui Xu, Ji Shi, Qing-Lin Qu, Xiao-Yan Guo, Rui Bai, Hua Xu, Jia-Dai Li, Jian-Yong Chen, Li-Juan High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma |
title | High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma |
title_full | High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma |
title_fullStr | High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma |
title_full_unstemmed | High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma |
title_short | High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma |
title_sort | high serum lactate dehydrogenase predicts an unfavorable outcome in chinese elderly patients with multiple myeloma |
topic | Clinical Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564653/ https://www.ncbi.nlm.nih.gov/pubmed/28418851 http://dx.doi.org/10.18632/oncotarget.16237 |
work_keys_str_mv | AT guyan highserumlactatedehydrogenasepredictsanunfavorableoutcomeinchineseelderlypatientswithmultiplemyeloma AT yuanyahui highserumlactatedehydrogenasepredictsanunfavorableoutcomeinchineseelderlypatientswithmultiplemyeloma AT xuji highserumlactatedehydrogenasepredictsanunfavorableoutcomeinchineseelderlypatientswithmultiplemyeloma AT shiqinglin highserumlactatedehydrogenasepredictsanunfavorableoutcomeinchineseelderlypatientswithmultiplemyeloma AT quxiaoyan highserumlactatedehydrogenasepredictsanunfavorableoutcomeinchineseelderlypatientswithmultiplemyeloma AT guorui highserumlactatedehydrogenasepredictsanunfavorableoutcomeinchineseelderlypatientswithmultiplemyeloma AT baihua highserumlactatedehydrogenasepredictsanunfavorableoutcomeinchineseelderlypatientswithmultiplemyeloma AT xujiadai highserumlactatedehydrogenasepredictsanunfavorableoutcomeinchineseelderlypatientswithmultiplemyeloma AT lijianyong highserumlactatedehydrogenasepredictsanunfavorableoutcomeinchineseelderlypatientswithmultiplemyeloma AT chenlijuan highserumlactatedehydrogenasepredictsanunfavorableoutcomeinchineseelderlypatientswithmultiplemyeloma |